China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK

By Adriano Marchese

Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding its manufacturing footprint in Europe.

The Tianjin, China-based company reached the agreement with Discovery Park, a science park in Sandwich, Kent, that offers lab space and offices to rent.

Asymchem said it will continue to operate the site as a clinical small molecule development and manufacturing facility that will aim to meet demand for pharmaceutical services and supply.

It also plans to expand the site to include capabilities to manufacture peptides and oligonucleotides, two molecular platforms important in making bioactive materials.

The development laboratories are expected to begin operation next month, followed by the API pilot plant later in August. Asymchem said it will maintain many staff previously employed by Pfizer.

Write to Adriano Marchese at [e-mail]

(END) Dow Jones Newswires

05-21-24 1425ET